Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing

被引:53
作者
Moss, CX
Villadangos, JA
Watts, C [1 ]
机构
[1] Univ Dundee, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland
[2] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia
[3] Walter & Eliza Hall Inst Med Res, Cooperat Res Ctr Vaccine Technol, Parkville, Vic, Australia
基金
英国惠康基金;
关键词
cathepsin D; cathepsin E; antigen processing; MHC class II; destructive processing;
D O I
10.1002/eji.200535320
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Whether specific proteases influence MHC class II antigen presentation is still not clearly defined. Cathepsin D, one of the most abundant lysosomal proteases, is thought to be dispensable for MHC class II antigen presentation, yet in vitro digestions of antigen substrates with endosomes/lysosomes from antigen-presenting cells sometimes reveal a dominant role for pepstatin-sensitive aspartyl proteases of which cathepsin D is the major representative. We tested whether the aspartyl protease substrate myoglobin requires cathepsin D activity for presentation to T cells. Surprisingly, in dendritic cells (DC) lacking cathepsin D, presentation of two different myoglobin T cell epitopes was enhanced rather than hindered. This paradox is resolved by the finding that pepstatin-sensitive myoglobin processing activity persists in lysosomes from cathepsin D-null DC and that this reduced activity, most likely due to cathepsin E, is closer to the optimum level required for myoglobin antigen presentation. Our results indicate redundancy among lysosomal aspartyl proteases and show that while processing activities can be productive for MHC class II T cell epitope generation at one level, they can become destructive above an optimal level.
引用
收藏
页码:3442 / 3451
页数:10
相关论文
共 48 条
[21]   PROCESSING OF THE PRECURSORS TO NEUROTENSIN AND OTHER BIOACTIVE PEPTIDES BY CATHEPSIN-E [J].
KAGEYAMA, T ;
ICHINOSE, M ;
YONEZAWA, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19135-19140
[22]   Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins [J].
Lich, JD ;
Elliott, JF ;
Blum, JS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (09) :1513-1523
[23]   Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase [J].
Loak, K ;
Li, DTN ;
Manoury, B ;
Billson, J ;
Morton, F ;
Hewitt, E ;
Watts, C .
BIOLOGICAL CHEMISTRY, 2003, 384 (08) :1239-1246
[24]   Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP [J].
Manoury, B ;
Mazzeo, D ;
Fugger, L ;
Viner, N ;
Ponsford, M ;
Streeter, H ;
Mazza, G ;
Wraith, DC ;
Watts, C .
NATURE IMMUNOLOGY, 2002, 3 (02) :169-174
[25]   An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation [J].
Manoury, B ;
Hewitt, EW ;
Morrice, N ;
Dando, PM ;
Barrett, AJ ;
Watts, C .
NATURE, 1998, 396 (6712) :695-699
[26]   Cellular distribution of napsin (kidney-derived aspartic protease-like protein, KAP) mRNA in the kidney, lung and lymphatic organs of adult and developing mice [J].
Mori, K ;
Kon, Y ;
Konno, A ;
Iwanaga, T .
ARCHIVES OF HISTOLOGY AND CYTOLOGY, 2001, 64 (03) :319-327
[27]   Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus [J].
Nakagawa, T ;
Roth, W ;
Wong, P ;
Nelson, A ;
Farr, A ;
Deussing, J ;
Villadangos, JA ;
Ploegh, H ;
Peters, C ;
Rudensky, AY .
SCIENCE, 1998, 280 (5362) :450-453
[28]   Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice [J].
Nakagawa, TY ;
Brissette, WH ;
Lira, PD ;
Griffiths, RJ ;
Petrushova, N ;
Stock, J ;
McNeish, JD ;
Eastman, SE ;
Howard, ED ;
Clarke, SRM ;
Rosloniec, EF ;
Elliott, EA ;
Rudensky, AY .
IMMUNITY, 1999, 10 (02) :207-217
[29]   Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia [J].
Nishioku, T ;
Hashimoto, K ;
Yamashita, K ;
Liou, SY ;
Kagamiishi, Y ;
Maegawa, H ;
Katsube, N ;
Peters, C ;
von Figura, K ;
Saftig, P ;
Katunuma, N ;
Yamamoto, K ;
Nakanishi, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) :4816-4822
[30]  
OZAKI S, 1988, J IMMUNOL, V141, P71